Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.

J Cardiovasc Electrophysiol

Cardiology Team, Department of Medicine & Geriatrics, Princess Margaret Hospital, Hong Kong, China.

Published: December 2005

Ketoconazole is not known to be proarrhythmic without concomitant use of QT interval-prolonging drugs. We report a woman with coronary artery disease who developed a markedly prolonged QT interval and torsades de pointes (TdP) after taking ketoconazole for treatment of fungal infection. Her QT interval returned to normal upon withdrawal of ketoconazole. Genetic study did not find any mutation in her genes that encode cardiac IKr channel proteins. We postulate that by virtue of its direct blocking action on IKr, ketoconazole alone may prolong QT interval and induce TdP. This calls for attention when ketoconazole is administered to patients with risk factors for acquired long QT syndrome.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1540-8167.2005.00299.xDOI Listing

Publication Analysis

Top Keywords

torsades pointes
8
concomitant interval-prolonging
8
ketoconazole
6
ketoconazole induced
4
induced torsades
4
pointes concomitant
4
interval-prolonging drug
4
drug ketoconazole
4
ketoconazole proarrhythmic
4
proarrhythmic concomitant
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!